Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-540716
Filing Date
2016-04-14
Accepted
2016-04-14 08:09:30
Documents
7
Effectiveness Date
2016-04-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A d126155ddefa14a.htm DEFA14A 33050
2 GRAPHIC g126550g05e15.jpg GRAPHIC 23408
3 GRAPHIC g126550g16q56.jpg GRAPHIC 13701
4 GRAPHIC g126550g62d05.jpg GRAPHIC 24728
5 GRAPHIC g126550g76c99.jpg GRAPHIC 32714
6 GRAPHIC g126550g87n84.jpg GRAPHIC 13084
7 GRAPHIC g126550g98q07.jpg GRAPHIC 27385
  Complete submission text file 0001193125-16-540716.txt   220612
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36199 | Film No.: 161570476
SIC: 2834 Pharmaceutical Preparations